Evidence map›Paper›PMID 18489015›Full record

Trial reportExperimental and clinical psychopharmacology2008

Bupropion improves attention but does not affect impulsive behavior in healthy young adults.

Ashley Acheson, Harriet de Wit

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Experimental and clinical psychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Dopamine and Temporal Discounting: Revisiting Pharmacology and Individual Differences.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Trial
  3. Trial
  4. Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Galantamine improves sustained attention in chronic cocaine users.Experimental and clinical psychopharmacology · 2011
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review: Suicide and its relationship to aggression and impulsivity.Cognitive, affective & behavioral neuroscience · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ashley AchesonDepartment of Pharmacology, Research Imaging Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. acheson@uthscsa.edu
Harriet de Wit
The University of Texas Health Science Center at San Antonio · USUniversity of Chicago · US

Funding

NEUROPSYCHOPHARMACOLOLGY TRG FOR DRUG ABUSE RESEARCHT32DA007255 · NIDA · UNIVERSITY OF CHICAGO · PI VEZINA, PAUL R · 1991 to 2012
$5.9M
REINSTATEMENT OF DRUG TAKINGR01DA009133 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1996 to 2009
$2.5M
NIDA NIH HHS DA 09133NIDA NIH HHS R01 DA009133NIDA NIH HHS T32 DA007255NIDA NIH HHS T32 DA 07255
6 · The paper itself

Abstract

Bupropion is an effective abstinence aid for cessation of smoking and possibly other drug use as well. There is evidence that bupropion improves attention and impulse control in certain patient populations, and improvements in these processes could mediate its efficacy as an abstinence aid. In the present study, we tested the effects of acute bupropion on measures of attention and impulsivity in healthy adults with d-amphetamine included as a positive control. Twenty-two nonsmokers (11 women) and 11 smokers (4 women) completed four 4-hr sessions where they received placebo, bupropion (150 or 300 mg), or d-amphetamine (20 mg) in capsules. Ninety minutes after capsule administration, participants were tested on attention with a simple reaction time task (SRT) and on impulsivity with the stop task, a delay and probability discounting task (DPD), and the balloon analogue risk task (BART). Participants also completed mood questionnaires during sessions. Bupropion (150 mg) decreased lapses in attention on the SRT, but did not affect performance on the stop task, DPD, or BART. Amphetamine decreased lapses in attention and speeded sensory motor processing time on the SRT but did not significantly affect responding on the stop task or DPD. On the BART, d-amphetamine tended to decrease risk taking in men but increased risk taking in women. Bupropion (300 mg) and d-amphetamine increased ratings of arousal. These results suggest that bupropion improves attention without affecting impulsive behavior in healthy adults. Improvements in attention may contribute to the effectiveness of bupropion as a pharmacotherapy for smoking.

Indexed as

AdolescentAdultAffectAttentionBupropionDopamine Uptake InhibitorsDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansImpulsive BehaviorIndolesMaleMiddle AgedSmokingSmoking CessationamphethinileBupropionDopamine Uptake InhibitorsIndoles

Identifiers

PMID18489015
PMCPMC4270475
OpenAlexW2072489212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.